Am J Surg
- SONG Z, Akund R, Wu C, Fazendin J, et al
Performance of molecular testing for indeterminate thyroid nodules in Black
patients.
Am J Surg. 2025;250:116569.
- LUI MS, Hangge PT, DeLozier O, Patel KN, et al
More than just stuck in the middle: papillary thyroid cancer of the isthmus may
present with aggressive features and nodal metasasis.
Am J Surg. 2025;250:116621.
- LIOU R, Slattery L, Hu Y, Kuo EJ, et al
Short-term outcomes in radiofrequency ablation for the primary treatment of
T1N0M0 papillary thyroid carcinomas.
Am J Surg. 2025 Oct 31:116702. doi: 10.1016/j.amjsurg.2025.116702.
BMC Cancer
- EROGLU I, Mohring C, Sadeghlar F, Manczak A, et al
Efficacy and safety of neoadjuvant FLOT treatment for resectable
gastric/gastroesophageal junction adenocarcinoma in Turkish and German patients;
a real-world data.
BMC Cancer. 2025;25:1754.
- YANG P, Liu S, Chen X, Xin H, et al
Muscle-specific MRI grading of soft tissue involvement provides additional
prognostic value beyond skull base criteria in nasopharyngeal carcinoma: a
retrospective study.
BMC Cancer. 2025;25:1751.
- PENG Y, Huang K, Gong Z, Liu W, et al
Nonenhanced CT-Based radiomics model enhances PTC detection in Hashimoto's
thyroiditis.
BMC Cancer. 2025;25:1760.
Dis Esophagus
- TOSHIYAMA S, Honda M, Murakami M, Kikuchi Y, et al
Proton beam-based chemoradiotherapy versus surgery plus adjuvant chemotherapy for
esophageal squamous cell carcinoma: a comparison of the long-term survival from a
single-center cohort study.
Dis Esophagus. 2025;38:doaf099.
- JONES DG, Grimminger P, Reynolds J, Rosati R, et al
Toward standardization in esophageal cancer surgery: patterns of practice across
high-volume European centers.
Dis Esophagus. 2025;38:doaf100.
Histopathology
- SUN M, Fu L, Ren H, Wang J, et al
Two similar but distinct types of breast acinar cell carcinoma: evidence from
histological, immunohistochemical and molecular features.
Histopathology. 2025;87:904-914.
- BELL PD, Kaul V, Bittner KM, Chen IY, et al
Margin clearance and post-procedure ablation decrease recurrence risk in
endoscopic mucosal resections for Barrett's-related neoplasia.
Histopathology. 2025;87:856-868.
Hum Pathol
- BEDELL M, Skaugen JM, Nikiforov Y, Reyes-Mugica M, et al
Non-invasive follicular thyroid neoplasm with papillary-like nuclear features
(NIFTP) in the adolescent and young adult population: A pediatric center
experience.
Hum Pathol. 2025;165:105951.
Int J Cancer
- WANG Y, Xi Y, Qiao L, Yu Y, et al
Ethnic, sex, and age disparities in esophageal cancer and medical costs: A
population-based study of 18 million people in China.
Int J Cancer. 2025 Nov 11. doi: 10.1002/ijc.70236.
Oral Oncol
- VAN LOOCKE P, Beuselinck B, Meulemans J, Nuyts S, et al
Impact of time-of-day administration of immune checkpoint inhibitors on survival
outcomes in patients with recurrent/metastatic head and neck cancer (R/M HNSCC):
a retrospective cohort study.
Oral Oncol. 2025;171:107772.
- DIEZ-FRAILE A, Pottel L, Lamoral P, De Backer T, et al
Age and surgical complexity outperform preoperative Geriatric-8 for 30-day major
complications in older head and neck cancer.
Oral Oncol. 2025;171:107774.
- DOERFLER R, Chen J, Kim C, Smith JD, et al
Integrating artificial intelligence-driven digital pathology and genomics to
establish patient-derived organoids as new approach methodologies for drug
response in head and neck cancer.
Oral Oncol. 2025;171:107742.
- OKURA M, Yamakawa N, Otsuru M, Hasegawa T, et al
T4a classification for oral cancer using mandibular canal invasion instead of
bone marrow invasion in the TNM staging system.
Oral Oncol. 2025;171:107771.
- ZHANG Y, Liu Z, Wu C, Li G, et al
Determination of the pathological staging of the oral squamous cell carcinoma
based on microscopic hyperspectral imaging.
Oral Oncol. 2025;170:107686.
- ZHANG Q, Luo X, Fu M, Peng B, et al
Whole-exome sequencing reveals the mutational landscape of head and neck
lymphoepithelioma-like carcinoma.
Oral Oncol. 2025;170:107695.
- GONG J, Han B, Tang X, Men Y, et al
Intraoral microvascular anastomosis: A minimally invasive technique for lateral
arm free flap tongue reconstruction.
Oral Oncol. 2025;170:107656.
- PALATNIK B, Kazadi D, Jethwa A, Nelson A, et al
Genomic evolution of a metastatic oral squamous cell carcinoma: a case report,
molecular analysis, and review of the literature.
Oral Oncol. 2025;170:107734.
- MARUDHUPANDI T
Letter to the Editor: Whole-exome sequencing reveals the mutational landscape of
head and neck lymphoepithelioma-like carcinoma.
Oral Oncol. 2025;170:107740.
- HE X, Xu Y, Ren Y, Wang J, et al
Neoadjuvant chemotherapy combined with anti-PD-1 monoclonal antibody in locally
advanced resectable oral squamous cell carcinoma: efficacy evaluation and
prediction.
Oral Oncol. 2025;170:107744.
- MARUDHUPANDI T
Predictive value of circulating tumor tissue-modified HPV DNA kinetics in
induction therapy for oropharyngeal squamous cell carcinoma.
Oral Oncol. 2025;170:107746.
- LI R, Ma S, Tang T, Zhao Y, et al
Prognostic impact and risk factors of level IV/V lymph nodes metastasis in
laryngeal squamous cell carcinoma.
Oral Oncol. 2025;170:107758.
- ZHAO P, Shen Q, Wang J, Chen Y, et al
Prognostic factors of head and neck osteosarcoma: A 10-year retrospective study
from a single institute.
Oral Oncol. 2025;170:107759.
- MARUDHUPANDI T
Letter to the Editor: Developing a predictive nomogram model for incidence of
adverse outcomes in oral and maxillofacial tumor patients undergoing free flap
reconstruction.
Oral Oncol. 2025;170:107751.
- WILLIAMS MM, Hanna GJ, Sethi RK, Rettig EM, et al
Outcomes of oropharyngeal squamous cell carcinoma among patients with
lymphoproliferative disorders.
Oral Oncol. 2025;170:107761.
Otolaryngol Head Neck Surg
- ROSEN R, Richter J, Cabrera CI, Karasik D, et al
Long-Term Opioid Use After Treatment of Head and Neck Cancers: A Systematic
Review and Meta-analysis.
Otolaryngol Head Neck Surg. 2025 Nov 12. doi: 10.1002/ohn.70024.
PLoS One
- LABOREY M, Lajoinie A, Freilich J, Samalin E, et al
Methodological approach to optimize a step-by-step deterministic linkage of SNDS
data with a clinical database (FREGAT) of gastric/gastroesophageal junction
adenocarcinoma in France: Pitfalls and learnings.
PLoS One. 2025;20:e0333667.
- CHOI YK, Son SH, Jang HS, Kim IH, et al
Prognostic role of effective radiation dose to immune cells in esophageal cancer
treated with definitive chemoradiation.
PLoS One. 2025;20:e0336794.
Radiother Oncol
- VISCHIONI B, Bonora M, Fontana G, Scardo S, et al
Prognostic factors and clinical outcomes in a large cohort of head and neck
adenoid cystic carcinoma patients treated with proton beam therapy: Insights from
an Italian referral center.
Radiother Oncol. 2025;213:111143.
- ALYAMANI N, Abrunhosa-Branquinho A, Corning C, Sharabiani M, et al
Radiotherapy quality assurance of the prospective randomised
EORTC-1219/DAHANCA-29 trial: an individual case review analysis.
Radiother Oncol. 2025;213:111141.
- JIANG W, Xiao Y, Hu H, Li J, et al
Postoperative Intensity-Modulated radiotherapy with trigeminal nerve pathway
delineation for head and neck adenoid cystic carcinoma.
Radiother Oncol. 2025;213:111174.
Thyroid
- VAN DE BERG DJ, Vriens MR, van Santen HM, Seur A, et al
Core Outcome Set of the Surgical Treatment of Differentiated Thyroid Carcinoma:
International Consensus by Delphi Study.
Thyroid. 2025 Nov 7. doi: 10.1177/10507256251390871.
- SCHONEBAUM LE, Oudijk L, Stegenga MT, Bramer WM, et al
The Prognostic Value of Immunohistochemical Biomarkers in Medullary Thyroid
Carcinoma: A Systematic Review and Meta-Analysis.
Thyroid. 2025 Nov 6. doi: 10.1177/10507256251393208.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016